Concepedia

Kiyoko Fujita

KF

Statistics

Publications

10

Citations

217

H-Index

10

Active since

2001

Affiliations

Taisho Pharmaceutical (Japan)(Current)

Tokyo University of Science

Medical & Biological Laboratories (Japan)

Kiyoko Fujita is an author at Taisho Pharmaceutical (Japan) specializing in life sciences, medicinal chemistry, and molecular biology.

Publications per year

2001–2022

10

Publications

10

Terminal deoxynucleotidyltransferase is negatively regulated by direct interaction with proliferating cell nuclear antigen

Shirou Ibe, Kiyoko Fujita, T. Toyomoto et al. · Genes to Cells · 2001 · 33 citations

, , +17

Terminal deoxynucleotidyltransferase directly interacts with a novel nuclear protein that is homologous to p65

Nobuyuki Yamashita, Noriko Shimazaki, Shiro Ibe et al. · Genes to Cells · 2001 · 32 citations · Full text

, , +11

Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity

Yousuke Yamada, Hajime Takashima, Lee Walmsley et al. · Journal of Medicinal Chemistry · 2020 · 31 citations · Full text

, , +16

Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: Discovery of TP0586532

Fumihito Ushiyama, Hajime Takashima, Yohei Matsuda et al. · Bioorganic & Medicinal Chemistry · 2020 · 23 citations · Full text

, , +9

Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases

Yusuke Oka, Tetsuya Yabuuchi, Takahiro Oi et al. · Bioorganic & Medicinal Chemistry · 2013 · 21 citations · Full text

, , +11

1–5 of 10